Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule
- PMID: 20370558
- DOI: 10.3109/10715761003692529
Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule
Abstract
Real time oxidative stress in the extracellular compartment of rat striatum was characterized by microdialysis with synthetic non-dialyzable marker molecules composed of linoleic acid, tyrosine and guanosine (N-linoleoyl tyrosine (LT) and N-linoleoyl tyrosine 2'-deoxyguanosyl ester (LTG)). Partial dopaminergic deafferentation was induced by injection of 6-hydroxydopamine (250 microg) to the left lateral ventricle, which depleted ipsilateral striatal dopamine by 46% and dopaminergic cells in left substantia nigra by 44%, 5 weeks after administration. Resting microdialysate dopamine levels in dopamine-depleted striatum were not different from sham-operated rats, although the ratio of oxidized metabolites of dopamine to free dopamine was significantly increased. Hydroperoxide and epoxy products of the linoleoyl portion of LT and LTG were detected in the striatal microdialysate by LC/MS/MS following initial separation by HPLC and were significantly increased in dopamine-depleted compared with control striatum without an increase in guanosine or tyrosine oxidation or nitration. Systemic administration of N-acetyl cysteine (350 mg/kg i.p.) decreased the increment in hydroperoxide and epoxy metabolites to levels not significantly different from control. Oxidation activity towards polyunsaturated fatty acids is present in the extracellular space of partially dopamine-denervated striatum, whereas oxidized glutathione and oxysterol levels in striatal tissue are decreased, possibly indicative of a compensatory response.
Similar articles
-
Alterations in striatal oxidative stress level produced by pharmacological manipulation of dopamine as shown by a novel synthetic marker molecule.Neuropharmacology. 2011 Jul-Aug;61(1-2):87-94. doi: 10.1016/j.neuropharm.2011.03.006. Epub 2011 Mar 21. Neuropharmacology. 2011. PMID: 21414328
-
Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.Exp Neurol. 2005 Jun;193(2):420-6. doi: 10.1016/j.expneurol.2005.01.010. Exp Neurol. 2005. PMID: 15869944
-
Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.Neuropharmacology. 2013 Feb;65:48-57. doi: 10.1016/j.neuropharm.2012.08.023. Epub 2012 Sep 7. Neuropharmacology. 2013. PMID: 22982254
-
[The application of LC-MS/MS in measurement of oxidative stress parameters].Wei Sheng Yan Jiu. 2009 Nov;38(6):757-61. Wei Sheng Yan Jiu. 2009. PMID: 20047241 Review. Chinese.
-
[Selective sensitivity of the striatum to oxidative stress].Vojnosanit Pregl. 1997 Nov-Dec;54(6 Suppl):33-43. Vojnosanit Pregl. 1997. PMID: 9481947 Review. Serbian. No abstract available.
Cited by
-
Smelling the Disease: Diagnostic Potential of Breath Analysis.Mol Diagn Ther. 2023 May;27(3):321-347. doi: 10.1007/s40291-023-00640-7. Epub 2023 Feb 2. Mol Diagn Ther. 2023. PMID: 36729362 Free PMC article. Review.
-
Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse.Brain Res. 2011 Mar 25;1382:315-20. doi: 10.1016/j.brainres.2011.01.061. Epub 2011 Jan 26. Brain Res. 2011. PMID: 21276430 Free PMC article.
-
N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson's Disease Rat Model.Antioxidants (Basel). 2023 Jun 11;12(6):1257. doi: 10.3390/antiox12061257. Antioxidants (Basel). 2023. PMID: 37371987 Free PMC article.
-
Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.Toxicol Appl Pharmacol. 2016 Apr 1;296:19-30. doi: 10.1016/j.taap.2016.02.010. Epub 2016 Feb 12. Toxicol Appl Pharmacol. 2016. PMID: 26879220 Free PMC article.
-
In Vivo Brain Glutathione is Higher in Older Age and Correlates with Mobility.Cereb Cortex. 2021 Aug 26;31(10):4576-4594. doi: 10.1093/cercor/bhab107. Cereb Cortex. 2021. PMID: 33959751 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources